Nobuhiro Inatomi (1), Fumihiko Sato (1), Shogo Marui (2), Zen Itoh (3) and Satoshi Omura (4)
(1) Pharmaceutical Research Laboratories III and (2) Pharmaceutical Research Laboratories I, Takeda Chemical Industries, Ltd., 2-17-85 Juso-Honmachi, Yodogawa-ku, Osaka 532, Japan (3) GI Laboratory, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371, Japan (4) The Kitasato Institute, Tokyo 108, Japan
Abstract: The motor-stimulating action of de(N-methyl)-N-isopropyl-8,9-anhydroerythromycin A 6,9- hemiacetal (EM574) on the upper gastrointestinal tract was studied in fasted conscious dogs using chronically implanted force transducers and compared with those of porcine motilin and cisapride. EM574 induced gastric phase III-like migrating contractions and increased the plasma motilin levels slightly. The gastric motility induced by low doses of EM574 and motilin was abolished by a 5HT3-receptor antagonist ondansetron and acute vagal blockade, whereas under these conditions, high doses of both agents induced contractions, which were abolished by atropine. Cisapride-induced gastric motility was inhibited by atropine and acute vagal blockade, but not by ondansetron. EM574 did not stimulate gastric secretion in the basal state. These results indicate that EM574- and motilin-induced gastrointestinal motility is attributable mainly to motor-stimulating vagal cholinergic neurons, and 5HT3-receptors are probably involved in the process. At high doses, EM574 and motilin also appear to stimulate cholinergic neurons in a non-vagal pathway, probably the enteric nervous system.
EM574, Motilin, Cisapride, Cholinergic neuron, Enteric nervous system
[Back to TOC]